HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (14) Citing Articles via Google Scholar Google Scholar Articles by Cole, B. J. Articles by Schumacher, H. R. Search for Related Content PubMed PubMed Citation Articles by Cole, B. J. Articles by Schumacher, H. R., Jr

Injectable Corticosteroids in Modern Practice

Dr. Cole is Director, Rush Cartilage Restoration Center, Rush University Medical Center, Chicago, IL. Dr. Schumacher is Chief of Rheumatology, VA Medical Center, Philadelphia, PA.

Reprint requests: Dr. Cole, Rush University Medical Center, Suite 1063, 1725 W Harrison Avenue, Chicago, IL 60612.

Long-lasting, crystalline suspensions of injectable corticosteroids have been used to treat joint and soft-tissue disorders for many years; they decrease inflammation by reducing local infiltration of inflammatory cells and mediators. Depot formulations differ in their characteristics. Compounds with low solubility are thought to have the longest duration of action but may cause tissue atrophy when used in soft tissues. Intra-articular corticosteroids are commonly used to treat osteoarthritis and inflammatory arthritis: meta-analyses confirm their benefit in reducing pain and symptoms. Intra-articular corticosteroid injections have been shown to be safe and effective for repeated use (every 3 months) for up to 2 years, with no joint space narrowing detected. Fewer clinical trials are available for extra-articular uses for injectable corticosteroids, although there is evidence of efficacy in a variety of soft-tissue conditions. The accuracy of injections affects outcomes. Postinjection flare, facial flushing, and skin and fat atrophy are the most common side effects. Systemic complications of injectable corticosteroids are rare.

This article has been cited by other articles:

				J.-P. Sylvestre, R. H Guy, and M B. Delgado-Charro In Vitro Optimization of Dexamethasone Phosphate Delivery by Iontophoresis Physical Therapy, October 1, 2008; 88(10): 1177 - 1185. [Abstract] [Full Text] [PDF]

				J. D. Rompe and N. Maffulli Repetitive shock wave therapy for lateral elbow tendinopathy (tennis elbow): a systematic and qualitative analysis Br. Med. Bull., September 1, 2007; 83(1): 355 - 378. [Abstract] [Full Text] [PDF]